Uncertainty and hope in people with metastatic uveal melanoma in the era of immunotherapy and targeted treatments: a theory-based qualitative study.
- Publisher:
- BMC
- Publication Type:
- Journal Article
- Citation:
- BMC Cancer, 2025, 25, (1), pp. 939
- Issue Date:
- 2025-05-26
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author |
Luckett, T |
|
dc.contributor.author | Ng, C-A | |
dc.contributor.author | Lai-Kwon, J | |
dc.contributor.author | Kee, D | |
dc.contributor.author |
Mulhern, B |
|
dc.contributor.author | Joshua, AM | |
dc.date.accessioned | 2025-07-01T01:07:55Z | |
dc.date.available | 2025-05-20 | |
dc.date.available | 2025-07-01T01:07:55Z | |
dc.date.issued | 2025-05-26 | |
dc.identifier.citation | BMC Cancer, 2025, 25, (1), pp. 939 | |
dc.identifier.issn | 1471-2407 | |
dc.identifier.issn | 1471-2407 | |
dc.identifier.uri | http://hdl.handle.net/10453/188009 | |
dc.description.abstract | BACKGROUND: The advent of immunotherapies and targeted treatments has improved survival for some people with metastatic cancer but also increased prognostic uncertainty. To inform clinician-patient communication and supportive care, this study explored uncertainty-related coping among people with metastatic uveal melanoma (mUM) - a disease for which treatments have emerged especially suddenly. METHODS: A qualitative approach was taken using semi-structured interviews. Participants with mUM were recruited through consumer organisations internationally. Interviews explored participant perspectives on the impacts of uncertainty and their related coping strategies. Analysis involved inductive coding followed by deductive coding against Mishel's (1988) theoretical framework of uncertainty in illness. RESULTS: Seventeen people participated, including 10 from Australia. Participants described experiencing uncertainty as disempowering but also leveraged the opportunity it presented for remaining hopeful. Some participants used meta-cognition- alluded to as 'tricking' or 'fooling' themselves - to manage inconsistency between hoping for an exceptional response and accepting that benefits were likely to be modest at best. Most participants were able to maintain everyday normalcy but struggled to discuss their illness and treatment with family and friends. Participants reported heightened anxiety in the lead-up to routine scans and while awaiting results. CONCLUSIONS: Coping with uncertainty in the era of immunotherapy and targeted treatments involves 'hoping for the best while preparing for the worst'. Supportive care is especially needed at the time of scans. Some patients may also benefit from help with talking to their social networks. Head-to-head comparisons are needed of differing psychological interventions. | |
dc.format | Electronic | |
dc.language | eng | |
dc.publisher | BMC | |
dc.relation.ispartof | BMC Cancer | |
dc.relation.isbasedon | 10.1186/s12885-025-14368-6 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 1112 Oncology and Carcinogenesis, 1117 Public Health and Health Services | |
dc.subject.classification | Oncology & Carcinogenesis | |
dc.subject.classification | 3211 Oncology and carcinogenesis | |
dc.subject.classification | 4202 Epidemiology | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Melanoma | |
dc.subject.mesh | Uveal Neoplasms | |
dc.subject.mesh | Uncertainty | |
dc.subject.mesh | Uveal Melanoma | |
dc.subject.mesh | Female | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Qualitative Research | |
dc.subject.mesh | Immunotherapy | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Adaptation, Psychological | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Hope | |
dc.subject.mesh | Molecular Targeted Therapy | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Melanoma | |
dc.subject.mesh | Uveal Neoplasms | |
dc.subject.mesh | Immunotherapy | |
dc.subject.mesh | Uncertainty | |
dc.subject.mesh | Adaptation, Psychological | |
dc.subject.mesh | Qualitative Research | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Female | |
dc.subject.mesh | Male | |
dc.subject.mesh | Molecular Targeted Therapy | |
dc.subject.mesh | Hope | |
dc.subject.mesh | Uveal Melanoma | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Melanoma | |
dc.subject.mesh | Uveal Neoplasms | |
dc.subject.mesh | Uncertainty | |
dc.subject.mesh | Uveal Melanoma | |
dc.subject.mesh | Female | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Qualitative Research | |
dc.subject.mesh | Immunotherapy | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Adaptation, Psychological | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Hope | |
dc.subject.mesh | Molecular Targeted Therapy | |
dc.subject.mesh | Australia | |
dc.title | Uncertainty and hope in people with metastatic uveal melanoma in the era of immunotherapy and targeted treatments: a theory-based qualitative study. | |
dc.type | Journal Article | |
utslib.citation.volume | 25 | |
utslib.location.activity | England | |
utslib.for | 1112 Oncology and Carcinogenesis | |
utslib.for | 1117 Public Health and Health Services | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | University of Technology Sydney/UTS Groups | |
pubs.organisational-group | University of Technology Sydney/UTS Groups/Centre for Health Economics Research and Evaluation (CHERE) | |
pubs.organisational-group | University of Technology Sydney/UTS Groups/Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT) | |
utslib.copyright.status | open_access | * |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.date.updated | 2025-07-01T01:07:51Z | |
pubs.issue | 1 | |
pubs.publication-status | Published online | |
pubs.volume | 25 | |
utslib.citation.issue | 1 |
Abstract:
BACKGROUND: The advent of immunotherapies and targeted treatments has improved survival for some people with metastatic cancer but also increased prognostic uncertainty. To inform clinician-patient communication and supportive care, this study explored uncertainty-related coping among people with metastatic uveal melanoma (mUM) - a disease for which treatments have emerged especially suddenly. METHODS: A qualitative approach was taken using semi-structured interviews. Participants with mUM were recruited through consumer organisations internationally. Interviews explored participant perspectives on the impacts of uncertainty and their related coping strategies. Analysis involved inductive coding followed by deductive coding against Mishel's (1988) theoretical framework of uncertainty in illness. RESULTS: Seventeen people participated, including 10 from Australia. Participants described experiencing uncertainty as disempowering but also leveraged the opportunity it presented for remaining hopeful. Some participants used meta-cognition- alluded to as 'tricking' or 'fooling' themselves - to manage inconsistency between hoping for an exceptional response and accepting that benefits were likely to be modest at best. Most participants were able to maintain everyday normalcy but struggled to discuss their illness and treatment with family and friends. Participants reported heightened anxiety in the lead-up to routine scans and while awaiting results. CONCLUSIONS: Coping with uncertainty in the era of immunotherapy and targeted treatments involves 'hoping for the best while preparing for the worst'. Supportive care is especially needed at the time of scans. Some patients may also benefit from help with talking to their social networks. Head-to-head comparisons are needed of differing psychological interventions.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph